IPSC
NASDAQ · Biotechnology
Century Therapeutics Inc
$2.19
-0.07 (-3.10%)
Open$2.29
Previous Close$2.26
Day High$2.42
Day Low$2.19
52W High$3.04
52W Low$0.34
Volume—
Avg Volume1.96M
Market Cap370.23M
P/E Ratio—
EPS$-0.11
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+1,148.9% upside
Current
$2.19
$2.19
Target
$27.35
$27.35
$22.03
$27.35 avg
$42.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 231.15M | 24.41M | 24.82M |
| Net Income | -20,289,274 | -1,389,193 | -1,166,783 |
| Profit Margin | -8.8% | -5.7% | -4.7% |
| EBITDA | -8,247,672 | -1,777,503 | -1,974,923 |
| Free Cash Flow | — | -1,484,406 | -1,631,995 |
| Rev Growth | +175.9% | +22.2% | +16.0% |
| Debt/Equity | — | 0.27 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |